Perceived Organizational Support and Job Performance: Mediating and Psycholoigical Role of Organizational Citizenship Behavior

Abstract

Introduction: The most severe kind of mental disease, schizophrenia is the standard example of a psychotic illness. Approximately 1 in 100 person’s worldwide struggle with this issue. A progressive transition away from Psychodynamic therapy and toward biological approaches to treatment has occurred since the creation of the first antipsychotic medications in the 1950s.A global health problem is being created by the aging schizophrenic population and the changing demography. Soon, the proportion of persons with schizophrenia in the world's population who are 55 and older will reach 25% or higher Among those aged 60 and Elders with mental health and substance use issues, schizophrenia ranks third in terms of the most prevalent cause of years lived with a handicap. 

Objectives: In this paper we explore the the effects of Psychodynamic therapy in treating Schizophrenia among elder patients.

Methods: A progressive transition away from Psychodynamic therapy and toward biological approaches to treatment has occurred since the creation of the first schizophrenia medications. The effect of older persons with schizophrenia on health care expenses is expected to be larger than other disorders, both physical and mental, resulting in increased patient expenses. Schizophrenia may manifest as incapacitating delusions, extremely disorganized cognition and behavior, and incapacitating hallucinations.

Results: The results of this study suggest that older patients with Schizophrenia who had psychodynamic therapy gradually improved over time.

Conclusions: The current knowledge of schizophrenia in the elderly suggests a different clinical picture from that of younger patients. More research into the neurobiology behind schizophrenia's clinical characteristics and developing of age-appropriate care and therapy are needed to address the disorder's deficiencies in the elderly.